OBJECTIVES: To estimate where intermittent preventive treatment (IPTp) using sulphadoxine-pyrimethamine (SP) could be withdrawn as an intervention due to declining malaria transmission intensity, or due to increasing prevalence of the Plasmodium falciparum dihydropteroate synthetase resistance mutation at codon 581G. METHODS: We conducted a systematic review and meta-analysis of protection against the incidence of low birth weight (LBW) conferred by ≥2 doses of IPTp-SP. We matched these outcomes to a proxy measure of malaria incidence in women of the same studies, applied meta-regression models to these data and conducted sensitivity analysis of the 581G mutation. RESULTS: Variation in the protective effect of IPTp-SP against LBW could not be explained by malaria transmission intensity. Among primi- and secundigravidae, IPTp-SP protected against LBW where 581G was ≤10.1% [odds ratio (OR): 0.49; 95% confidence intervals (CI): 0.29, 0.81; P = <0.01] and 581G was >10.1% (OR = 0.73; 95% CI: 0.29, 1.81; P = 0.03). Random-effects models among multigravidae showed that IPTp-SP protects against LBW where 581G was ≤10.1% (OR = 0.56; 95% CI: 0.37, 0.86; P = 0.07), a finding of borderline statistical significance. No evidence of protection against LBW was observed where 581G was >10.1% (OR = 0.96; 95% CI: 0.70, 1.34; P = 0.47). CONCLUSION: There appears to be a prevalence of 581G above which IPTp-SP no longer protects against LBW. Pregnancy studies are urgently needed where 581G is >10.1% to define the specific prevalence threshold where new strategies should be deployed.
OBJECTIVES: To estimate where intermittent preventive treatment (IPTp) using sulphadoxine-pyrimethamine (SP) could be withdrawn as an intervention due to declining malaria transmission intensity, or due to increasing prevalence of the Plasmodium falciparum dihydropteroate synthetase resistance mutation at codon 581G. METHODS: We conducted a systematic review and meta-analysis of protection against the incidence of low birth weight (LBW) conferred by ≥2 doses of IPTp-SP. We matched these outcomes to a proxy measure of malaria incidence in women of the same studies, applied meta-regression models to these data and conducted sensitivity analysis of the 581G mutation. RESULTS: Variation in the protective effect of IPTp-SP against LBW could not be explained by malaria transmission intensity. Among primi- and secundigravidae, IPTp-SP protected against LBW where 581G was ≤10.1% [odds ratio (OR): 0.49; 95% confidence intervals (CI): 0.29, 0.81; P = <0.01] and 581G was >10.1% (OR = 0.73; 95% CI: 0.29, 1.81; P = 0.03). Random-effects models among multigravidae showed that IPTp-SP protects against LBW where 581G was ≤10.1% (OR = 0.56; 95% CI: 0.37, 0.86; P = 0.07), a finding of borderline statistical significance. No evidence of protection against LBW was observed where 581G was >10.1% (OR = 0.96; 95% CI: 0.70, 1.34; P = 0.47). CONCLUSION: There appears to be a prevalence of 581G above which IPTp-SP no longer protects against LBW. Pregnancy studies are urgently needed where 581G is >10.1% to define the specific prevalence threshold where new strategies should be deployed.
Authors: Meghna Desai; Julie Gutman; Anne L'lanziva; Kephas Otieno; Elizabeth Juma; Simon Kariuki; Peter Ouma; Vincent Were; Kayla Laserson; Abraham Katana; John Williamson; Feiko O ter Kuile Journal: Lancet Date: 2015-09-28 Impact factor: 79.321
Authors: Victor S Koko; Marian Warsame; Benjamin Vonhm; Moses K Jeuronlon; Didier Menard; Laurence Ma; Fahn Taweh; Lekilay Tehmeh; Paye Nyansaiye; Oliver J Pratt; Sei Parwon; Patrick Kamara; Magnus Asinya; Aaron Kollie; Pascal Ringwald Journal: Malar J Date: 2022-04-27 Impact factor: 3.469
Authors: Esmée Ruizendaal; Henk D F H Schallig; Susana Scott; Maminata Traore-Coulibaly; John Bradley; Palpouguini Lompo; Hamtandi M Natama; Ousmane Traore; Innocent Valea; Susan Dierickx; Koiné M Drabo; Franco Pagnoni; Umberto d' Alessandro; Halidou Tinto; Petra F Mens Journal: Am J Trop Med Hyg Date: 2017-07-19 Impact factor: 2.345
Authors: Vera Braun; Eva Rempis; Alexandra Schnack; Sarah Decker; John Rubaihayo; Nazarius Mbona Tumwesigye; Stefanie Theuring; Gundel Harms; Priscilla Busingye; Frank P Mockenhaupt Journal: Malar J Date: 2015-09-26 Impact factor: 2.979
Authors: Reginald A Kavishe; Robert D Kaaya; Sidsel Nag; Camilla Krogsgaard; Jakob Ginsbak Notland; Adellaida A Kavishe; Deus Ishengoma; Cally Roper; Michael Alifrangis Journal: Malar J Date: 2016-06-23 Impact factor: 2.979
Authors: Mwayiwawo Madanitsa; Linda Kalilani; Victor Mwapasa; Anna M van Eijk; Carole Khairallah; Doreen Ali; Cheryl Pace; James Smedley; Kyaw-Lay Thwai; Brandt Levitt; Duolao Wang; Arthur Kang'ombe; Brian Faragher; Steve M Taylor; Steve Meshnick; Feiko O Ter Kuile Journal: PLoS Med Date: 2016-09-13 Impact factor: 11.069